New Key Statistics Module, Z-Score and F-Score
OSTO:BIOVIT Key Ratios
| Market Cap kr M | 50.44 |
| Enterprise Value kr M | 49.67 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 1.42 |
| Price/Sales | 21.33 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) kr M | 1.00 |
| EPS (TTM) kr | -0.14 |
| Beneish M-Score | 1.45 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 17.90 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -3.34 |
| EV-to-EBITDA | -10.17 |
| PEG | -- |
| Shares Outstanding M | 394.02 |
| Net Margin (%) | -1,334.08 |
| Operating Margin % | -1,339.75 |
| Pre-tax Margin (%) | -1,334.08 |
| Quick Ratio | 5.84 |
| Current Ratio | 8.50 |
| ROA % (ttm) | -49.88 |
| ROE % (ttm) | -58.48 |
| ROIC % (ttm) | -48.32 |
| Dividend Yield % | -- |
| Altman Z-Score | 94.86 |
OSTO:BIOVIT Number of Guru Trades
OSTO:BIOVIT Volume of Guru Trades
Gurus Latest Trades with OSTO:BIOVIT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OSTO:BIOVIT is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers